Clinical Trial Update: Monalizumab and Trastuzumab In Metastatic HER2-pOSitive breAst Cancer: MIMOSA-trial [Phase 2]

View source ↗

Summary

A Phase 2 trial (MIMOSA) evaluating Monalizumab in combination with Trastuzumab for metastatic HER2-positive breast cancer has completed enrollment/status, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Monalizumab (monalizumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED